ITU Unit Action

OLPRUVA

Acer Therapeutics Inc.

ITU Unit Action

Trademark Snap Shot ITU Unit Action
(Table presents the data on ITU Unit Action)

OVERVIEW

SERIAL NUMBER 88814846 FILING DATE 02/28/2020
REG NUMBER 0000000 REG DATE N/A
REGISTER PRINCIPAL MARK TYPE TRADEMARK
INTL REG # N/A INTL REG DATE N/A
TM ATTORNEY NKOJO, RHODA K
L.O. ASSIGNED 117

PUB INFORMATION

RUN DATE 08/13/2021
PUB DATE 06/23/2020
STATUS 731-SECOND EXTENSION - GRANTED
STATUS DATE 08/11/2021
LITERAL MARK ELEMENT OLPRUVA

DATE ABANDONED N/A DATE CANCELLED N/A
SECTION 2F NO SECTION 2F IN PART NO
SECTION 8 NO SECTION 8 IN PART NO
SECTION 15 NO REPUB 12C N/A
RENEWAL FILED NO RENEWAL DATE N/A
DATE AMEND REG N/A


FILING BASIS

FILED BASIS CURRENT BASIS AMENDED BASIS
1 (a) NO 1 (a) NO 1 (a) NO
1 (b) YES 1 (b) YES 1 (b) NO
44D NO 44D NO 44D NO
44E NO 44E NO 44E NO
66A NO 66A NO

NO BASIS NO NO BASIS NO


MARK DATA

STANDARD CHARACTER MARK YES
LITERAL MARK ELEMENT OLPRUVA
MARK DRAWING CODE 4-STANDARD CHARACTER MARK
COLOR DRAWING FLAG NO

CURRENT OWNER INFORMATION

PARTY TYPE 20-OWNER AT PUBLICATION
NAME Acer Therapeutics Inc.
ADDRESS One Gateway Center, Suite 351
300 Washington Street
Newton, MA 02458
ENTITY 03-CORPORATION
CITIZENSHIP Delaware

GOODS AND SERVICES

INTERNATIONAL CLASS 005
          DESCRIPTION TEXT Pharmaceuticals for the treatment of inborn errors of metabolism

GOODS AND SERVICES CLASSIFICATION

INTERNATIONAL CLASS 005 FIRST USE DATE NONE FIRST USE IN COMMERCE DATE NONE CLASS STATUS 6-ACTIVE

MISCELLANEOUS INFORMATION/STATEMENTS

CHANGE IN REGISTRATION NO

PROSECUTION HISTORY

DATE ENT CD ENT TYPE DESCRIPTION ENT NUM
08/13/2021 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED 015
08/11/2021 EX2G S EXTENSION 2 GRANTED 014
08/11/2021 EXT2 S EXTENSION 2 FILED 013
08/11/2021 EEXT I TEAS EXTENSION RECEIVED 012
02/12/2021 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED 011
02/10/2021 EX1G S EXTENSION 1 GRANTED 010
02/10/2021 EXT1 S EXTENSION 1 FILED 009
02/10/2021 EEXT I TEAS EXTENSION RECEIVED 008
08/18/2020 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT 007
06/23/2020 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED 006
06/23/2020 PUBO A PUBLISHED FOR OPPOSITION 005
06/03/2020 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED 004
05/20/2020 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER 003
05/19/2020 DOCK D ASSIGNED TO EXAMINER 002
03/06/2020 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM 001

CURRENT CORRESPONDENCE INFORMATION

ATTORNEY J. Cooper McDonald
CORRESPONDENCE ADDRESS J. Cooper McDonald
CLARK+ELBING LLP
101 FEDERAL STREET, 15TH FLOOR
BOSTON MA 02110
DOMESTIC REPRESENTATIVE NONE

PRIOR OWNER INFORMATION

PARTY TYPE 10-ORIGINAL APPLICANT
NAME Acer Therapeutics Inc.
ADDRESS One Gateway Center, Suite 351
300 Washington Street
Newton, MA 02458
ENTITY 03-CORPORATION
CITIZENSHIP Delaware

ITU Unit Action [image/jpeg]


uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed